Source - Alliance News
Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based medicines - Says it has received the final £103,000 from its £1.0 million draw down request under its committed credit facility. Says it has also received a £389,000 tax credit from a 2022 research & development claim. The company says it will continue to explore ‘further capital opportunities’.
Current stock price: 20.51 pence, up 14% in London on Wednesday morning
12-month change: down 82%
Copyright 2025 Alliance News Ltd. All Rights Reserved.
